Digg It - Business

Meetings are one of the most vital components of business, when they are used productively. So many people quote boring, unproducti

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ve meetings as being a 'waste of time', that some sense of it all is needed.

Managing meetings effectively will help you make the

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

est use of your and everyone else's time, whilst acknowledging the tremendous value of utilising those real opportunities where peo

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

le get together in a generative, growth focused way.

Using their time together wisely.

10 Simple Actions You Can Take Today!
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
>

Consider the meetings you took part in during the last week. Being really honest, how productive were they on a scale of
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro
1 to 10. What would a meeting with a score of 3 better have been like?

What can you do in preparation of the next meeting you
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
re involved, in to make it work better? Come on, get up and be the source of change!

Consider the behaviours in the meetings y
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ou are part of. How do you personally behave? Compare your contribution to others present. What can you do differently and how will
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
you get this embedded deeply.

In your next meeting, observe carefully where things start to go wrong - if they do. Where does
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
he responsibility for the meeting lie on this occasion?

Who gets involved in your meetings - and who doesn't? Be really focuse
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
about the value each gets from being there. Be prepared to exclude others - and be careful and generous with ow you let people dow
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a
.

What outcome would be the best possible from the meetings you go to, to really make a difference? What need for movement and
dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod
progress is everyone aware of?

Would you benefit from more or less meetings next week? Consider what you could do with the ext
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
a time. How do you balanced the added extra time with the loss of meeting value.

Ensure that everyone is clear of what is expe
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
cted of them and by when, as they leave the meeting. Get minutes out as soon as you can to ensure everyone is really clear.

Ho
t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
do you 'park' issues that come up that are not relevant to the meeting? What is the process for acknowledging the real issues peop
ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust
e face - but at some other time please.

Review each meeting you go to and look deeply at what went well, and what might have g
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ne better - what can you change yourself to make things run more effectively?

For much more on meetings, checkout the we
.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
page at the link below

The key to successful meetings is all about focus, treating each other well and having a game plan for succ
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip
ss.

In this way, meetings can be worth having, despite having, each and every one of us, sat through some horror shows in the past

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Digg It - Effectively Managing Meetings

Related Articles: